BriaCell Therapeutics Corp (BCTX) said Tuesday it has closed its best-efforts offering of roughly 1.45 million shares at $3.25 per share, for gross proceeds of about $4.7 million.
Net proceeds will be used for working capital, general corporate purposes, as well as the advancement of business goals, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments